Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02229-3Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

Source: Leukemia - March 26, 2024 Category: Hematology Authors: Hagop Kantarjian Susan Branford Massimo Breccia Jorge Cortes Fadi G. Haddad Andreas Hochhaus Timothy Hughes Ghayas C. Issa Elias Jabbour Franck E. Nicolini Koji Sasaki Francois Xavier-Mahon Source Type: research